Free Trial
NASDAQ:SSKN

STRATA Skin Sciences (SSKN) Stock Price, News & Analysis

STRATA Skin Sciences logo
$2.63 +0.01 (+0.38%)
Closing price 04/4/2025 03:49 PM Eastern
Extended Trading
$2.62 0.00 (-0.19%)
As of 04/4/2025 07:12 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About STRATA Skin Sciences Stock (NASDAQ:SSKN)

Key Stats

Today's Range
$2.54
$2.69
50-Day Range
$2.56
$2.99
52-Week Range
$2.51
$5.90
Volume
2,731 shs
Average Volume
12,069 shs
Market Capitalization
$10.97 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$6.00
Consensus Rating
Buy

Company Overview

STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. The company products include XTRAC and Pharos excimer lasers, and VTRAC lamp systems for the treatment systems that are used for the treatment of psoriasis, vitiligo, and other skin conditions. It also offers TheraClear Acne Therapy System for the treatment of mild to moderate inflammatory, comedonal, and pustular acne. The company was formerly known as MELA Sciences, Inc and changed its name to STRATA Skin Sciences, Inc. in January 2016. STRATA Skin Sciences, Inc. was incorporated in 1989 and is based in Horsham, Pennsylvania.

Remove Ads

STRATA Skin Sciences Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
51st Percentile Overall Score

SSKN MarketRank™: 

STRATA Skin Sciences scored higher than 51% of companies evaluated by MarketBeat, and ranked 413th out of 916 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    STRATA Skin Sciences has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    STRATA Skin Sciences has only been the subject of 1 research reports in the past 90 days.

  • Read more about STRATA Skin Sciences' stock forecast and price target.
  • Earnings Growth

    Earnings for STRATA Skin Sciences are expected to grow in the coming year, from ($1.05) to ($1.04) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of STRATA Skin Sciences is -0.99, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of STRATA Skin Sciences is -0.99, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    STRATA Skin Sciences has a P/B Ratio of 0.72. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about STRATA Skin Sciences' valuation and earnings.
  • Percentage of Shares Shorted

    0.09% of the float of STRATA Skin Sciences has been sold short.
  • Short Interest Ratio / Days to Cover

    STRATA Skin Sciences has a short interest ratio ("days to cover") of 0.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in STRATA Skin Sciences has recently increased by 35.29%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    STRATA Skin Sciences does not currently pay a dividend.

  • Dividend Growth

    STRATA Skin Sciences does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.09% of the float of STRATA Skin Sciences has been sold short.
  • Short Interest Ratio / Days to Cover

    STRATA Skin Sciences has a short interest ratio ("days to cover") of 0.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in STRATA Skin Sciences has recently increased by 35.29%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    STRATA Skin Sciences has a news sentiment score of 0.27. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.61 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 7 news articles for STRATA Skin Sciences this week, compared to 1 article on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, STRATA Skin Sciences insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    39.00% of the stock of STRATA Skin Sciences is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 32.43% of the stock of STRATA Skin Sciences is held by institutions.

  • Read more about STRATA Skin Sciences' insider trading history.
Receive SSKN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for STRATA Skin Sciences and its competitors with MarketBeat's FREE daily newsletter.

SSKN Stock News Headlines

Your Retirement Is Caught in the Crossfire
When Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. Now… as new tariffs take effect, gold is breaking records again. You've hopefully already seen this in action… but gold is surpassing $3,000 per ounce for the first time EVER.
Strata Skin Sciences (SSKN) Gets a Buy from Maxim Group
See More Headlines

SSKN Stock Analysis - Frequently Asked Questions

STRATA Skin Sciences' stock was trading at $2.91 at the start of the year. Since then, SSKN shares have decreased by 9.6% and is now trading at $2.63.
View the best growth stocks for 2025 here
.

STRATA Skin Sciences, Inc. (NASDAQ:SSKN) announced its quarterly earnings results on Thursday, March, 27th. The medical device company reported ($1.13) EPS for the quarter, missing analysts' consensus estimates of ($0.40) by $0.73. The medical device company had revenue of $33.56 million for the quarter, compared to analyst estimates of $9.03 million. STRATA Skin Sciences had a negative trailing twelve-month return on equity of 69.33% and a negative net margin of 28.72%.

STRATA Skin Sciences shares reverse split on Friday, June 7th 2024. The 1-10 reverse split was announced on Friday, June 7th 2024. The number of shares owned by shareholders was adjusted after the market closes on Friday, June 7th 2024. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Shares of SSKN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that STRATA Skin Sciences investors own include Amarin (AMRN), AbbVie (ABBV), OPKO Health (OPK), AT&T (T), Agile Therapeutics (AGRX), Advanced Micro Devices (AMD) and Avino Silver & Gold Mines (ASM).

Company Calendar

Last Earnings
3/27/2025
Today
4/04/2025
Next Earnings (Estimated)
4/28/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:SSKN
Employees
120
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$6.00
High Stock Price Target
$6.00
Low Stock Price Target
$6.00
Potential Upside/Downside
+128.1%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-10,830,000.00
Pretax Margin
-29.00%

Debt

Sales & Book Value

Annual Sales
$32.68 million
Price / Cash Flow
N/A
Book Value
$3.65 per share
Price / Book
0.72

Miscellaneous

Free Float
2,544,000
Market Cap
$10.97 million
Optionable
Not Optionable
Beta
1.32

Social Links

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for April 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NASDAQ:SSKN) was last updated on 4/5/2025 by MarketBeat.com Staff
From Our Partners